Evaluation of treatment and public funding landscape for Duchenne Muscular Dystrophy (DMD) in Algeria, Tunisia, and Morocco Read more
Strategic Assessment of the Multiple Sclerosis Market to Define Price and Access Potential for 4 Innovators in Emerging Markets Including South Africa Read more
In-depth Analysis of New Products in Multiple Sclerosis to Understand Product Positioning and Associate Product Potential in Key MEA Geographies Read more
Understanding Risks for Biosimilars in the MEA Region, and Associated Entry List and Net Prices Read more
